All In Biotech

Drug Trial Radar · NCT04987489

A Study of Etavopivat in Patients With Thalassemia or Sickle Cell Disease

A Phase 2 Open-Label Study to Evaluate Safety and Clinical Activity of Etavopivat in Patients With Thalassemia or Sickle Cell Disease

Last checked: Nov 19, 2026Latest source record: Dec 16, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

53

Actual

Start

Mar 28, 2022

Primary completion

Sep 3, 2025

Study completion Sep 24, 2025

Sponsor

Lead sponsor
Forma Therapeutics, Inc.Industry
Sponsor type
Industry
First posted
Aug 3, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Non randomized
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 12 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This clinical trial is a Phase 2 study that will evaluate the safety and clinical activity of etavopivat in patients with thalassemia or sickle cell disease and test how well etavopivat works to lower the number of red blood cell transfusions required and increase hemoglobin.

Conditions

  • Sickle Cell Disease
  • Thalassemia

Interventions

  • Etavopivat tabletsDrug

    Etavopivat 400 mg once daily

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Cohorts A: Proportion of patients with ≥ 20% reduction in red blood cell transfusions over a continuous 12-week treatment period versus baseline red blood cell transfusion historyTime frame: 12 weeks
  2. Cohorts B: Proportion of patients with ≥ 20% reduction in red blood cell transfusions over a continuous 12-week treatment period versus baseline red blood cell transfusion historyTime frame: 12 weeks
  3. Cohort C: Hemoglobin response rate at Week 12 (increase of ≥ 1.0 g/dL from baseline)Time frame: 12 weeks

Locations

32 sites in 6 countries. Site status is shown where the registry gives one.

  • TOI Clinical Research

    Cerritos, California

  • [Legal] Children's Hospital Los Angeles

    Los Angeles, California

  • University of Californ LA-UCLA

    Los Angeles, California

  • UCSF Oakland Benioff ChildHosp

    Oakland, California

  • [Legal] Children's Hospital of Orange County on behalf of CHOC Children's Hospital of Orange County

    Orange, California

  • UCI Health

    Orange, California

  • Children's National Health Hospital

    Washington D.C., District of Columbia

  • Children's Hospital of Atlanta

    Atlanta, Georgia

  • [Legal] Dr. Vince Clinical Research, LLC and Dr. Vince Clinical Research, P.A.

    Detroit, Michigan

  • Weill Medical College of Cornell University

    New York, New York

  • Duke University

    Durham, North Carolina

  • East Carolina University

    Greenville, North Carolina

  • [Legal] Children's Hospital Medical Center dba Cincinnati Children's

    Cincinnati, Ohio

  • Children's Hosptl Philadelphia

    Philadelphia, Pennsylvania

  • Master Centre for Canada

    Mississauga, Ontario, Canada

  • The Hospital for Sick Children

    Toronto, Ontario, Canada

  • University Health Network - Toronto General Hospital

    Toronto, Ontario, Canada

  • CHU Sainte-Justine Mother and Child University Hospital

    Montreal, Quebec, Canada

  • Cairo University

    Cairo, Egypt

  • Abu El-Reesh El-Mounira Children University Hospital

    Cairo, Egypt, Egypt

  • Galliera Hospital Centro Anemie Congenite

    Genova, Italy

  • Fondazione IRCSS Ca' Granda Ospedale Maggiore Policlinico

    Milan, Italy

  • AORN A. Cardarelli

    Naples, Italy

  • A.O.U. Università Studi della Campania "Luigi Vanvitelli"

    Naples, Italy

  • Chronic Care Center

    Baabda, Lebanon

  • Hospital Nini

    Tripoli, Lebanon

  • Sandwell and West Birmingham NHS Trust SCAT/ haematology

    Birmingham, United Kingdom

  • Barts Health NHS Trust - The Royal London Hospital

    London, United Kingdom

  • University College Hospital - University College London Hospitals NHS Foundation Trust

    London, United Kingdom

  • Kings College London

    London, United Kingdom

  • Hammersmith Hospital - London

    London, United Kingdom

  • Manchester University NHS Foundation Trust

    Manchester, United Kingdom

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.